WINDAMERE VENTURE PARTNERS
Since its inception in 1998, Windamere Venture Partners has supported more than a dozen pharmaceutical, biotechnology, medical device, and other healthcare companies from the very early stages. Their unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates-of-return for both entrepreneurs and investors.
WINDAMERE VENTURE PARTNERS
Social Links:
Founded:
1994-01-01
Status:
Active
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
LifeSci Venture Partners
LifeSci Venture Partners is an early-stage investment firm that invests in early-stage life sciences and healthcare companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-02-26 | Cianna Medical | Windamere Venture Partners investment in Series A - Cianna Medical | 9 M USD |
| 2007-01-08 | Proprius Pharmaceuticals | Windamere Venture Partners investment in Series A - Proprius Pharmaceuticals | 11 M USD |
| 2005-12-08 | Oculir | Windamere Venture Partners investment in Series A - Oculir | 7.3 M USD |
| 2005-06-09 | Verus Pharmaceuticals | Windamere Venture Partners investment in Series A - Verus Pharmaceuticals | 78 M USD |
| 2004-08-05 | Avera Pharmaceutical | Windamere Venture Partners investment in Series C - Avera Pharmaceutical | 48 M USD |
| 2004-06-15 | Somaxon Pharmaceuticals | Windamere Venture Partners investment in Series B - Somaxon Pharmaceuticals | 23 M USD |
| 2003-05-22 | Santarus | Windamere Venture Partners investment in Series D - Santarus | 51.4 M USD |
| 2002-12-04 | SkinMedica | Windamere Venture Partners investment in Series B - SkinMedica | 9 M USD |
| 2002-06-03 | Dexcom | Windamere Venture Partners investment in Series C - Dexcom | 30 M USD |
| 2001-03-08 | Santarus | Windamere Venture Partners investment in Series C - Santarus | 33.2 M USD |